← Female Fertility

Egg Quality and Natural Support

Evidence-based diet, lifestyle, and supplement approaches to improving oocyte quality, ovulation, and time to conception — including CoQ10, myo-inositol, vitamin D, omega-3, and the Mediterranean fertility diet

Female fertility depends on the quality of eggs that began forming before you were born — and that quality is more changeable than most women are told. Eggs spend their final 90 days maturing inside the ovary, and what happens to your body during that window — your nutrition, blood sugar, inflammation, sleep, and toxin exposure — directly shapes the egg released at ovulation. A landmark Nurses' Health Study II analysis of 17,544 women found that a "fertility diet" pattern combining whole grains, plant proteins, full-fat dairy, and a daily multivitamin lowered ovulatory infertility risk by 66%. [1] Mediterranean dietary patterns, CoQ10, myo-inositol, vitamin D, and omega-3 fats each have published evidence supporting oocyte quality, ovulation regularity, or time to conception. [2][4][5][6][7] Reducing pesticide exposure through organic produce choices is one of the more reliably useful interventions in the published IVF literature. [3]

How Egg Quality Actually Works

A woman is born with all the eggs she will ever have — roughly 1–2 million primordial follicles at birth, declining to about 300,000 by puberty and around 25,000 by age 37. But the eggs themselves are not "old" in any simple sense: each one sits in an arrested state until recruited into the final 90-day maturation window in the months before it is ovulated. During that window, the egg's mitochondria, cytoskeleton, and chromosome-segregation machinery are uniquely vulnerable to oxidative damage and metabolic disturbance. This is why interventions that take 3–4 months to show effects — and why women who change their diet, supplements, and lifestyle 90+ days before trying to conceive consistently see better outcomes than those who wait until they are already trying.

The two biggest determinants of egg quality during this maturation window are mitochondrial energy production and protection from oxidative stress. The mature human oocyte contains roughly 100,000 mitochondria — more than any other cell in the body — because the energy demands of meiosis (correctly separating chromosomes) and the early cell divisions after fertilisation are enormous. When mitochondrial ATP production falls, chromosome segregation errors rise sharply, leading to aneuploidy (the wrong chromosome count), which is the single biggest cause of failed implantation, early miscarriage, and age-related fertility decline.

The Fertility Diet: What 17,544 Women Showed

The Nurses' Health Study II followed 17,544 women trying to conceive over eight years and identified a dietary pattern linked to dramatically lower rates of ovulatory infertility. [1] Compared to women in the bottom quintile of "fertility diet" adherence, women in the top quintile had a 66% lower risk of ovulatory infertility and 27% lower risk of infertility from any cause. The pattern was characterised by:

  • More monounsaturated and less trans fats
  • More vegetable than animal protein
  • More high-fibre, low-glycaemic carbohydrates
  • More full-fat (rather than low-fat) dairy
  • More iron from plant sources
  • A daily multivitamin (folate appears to be the key driver here)

This pattern looks very similar to the Mediterranean diet, which a Spanish nested case-control study independently confirmed: women in the highest tertile of Mediterranean diet adherence were 44% less likely to consult for difficulty conceiving compared to the lowest tertile. [2] The biological logic is straightforward — these dietary patterns reduce systemic inflammation, stabilise insulin (excess insulin suppresses ovulation through effects on LH and free testosterone), and supply the methyl-donor B vitamins, antioxidants, and omega-3 fats that maturing follicles need.

See our Mediterranean diet page for more on the broader pattern, and our folate page for why the multivitamin element matters.

CoQ10: Powering the Aging Oocyte

CoQ10 (ubiquinone/ubiquinol) is a fat-soluble component of the mitochondrial electron transport chain and a potent antioxidant. As women age, follicular fluid CoQ10 levels decline, and the oocyte's mitochondria become less efficient at producing the ATP required for accurate chromosome segregation. A small randomised pilot in women aged 38–46 undergoing IVF found that 600 mg/day of CoQ10 for 60 days before retrieval reduced the proportion of aneuploid embryos compared to controls (46.5% vs 62.8%), although the trial was halted early and underpowered for definitive conclusions. [5]

The clinical doses used in trials are 200–600 mg/day of ubiquinone (or 100–300 mg of the more bioavailable ubiquinol form), started at least 60–90 days before a conception attempt or IVF cycle. Combined with the timeline of follicle maturation, this is one of the better-supported supplements for women 35+.

Myo-Inositol: The PCOS Game-Changer

For women with polycystic ovary syndrome (PCOS) — the most common cause of ovulatory infertility — myo-inositol is among the best-supported natural interventions. A 2017 meta-analysis of nine randomised controlled trials found that myo-inositol significantly improved ovulation, restored regular cycles, and improved oocyte and embryo quality in PCOS patients. [4] Clinical doses are 2 g taken twice daily, often combined with 50 mcg D-chiro-inositol in a 40:1 ratio. The mechanism is restoration of normal insulin signalling within ovarian theca and granulosa cells, which corrects the hyperandrogenism and ovulatory dysfunction that defines the syndrome.

See our PCOS page and our inositol page for more.

Vitamin D: Don't Skip the Test

A 2018 systematic review and meta-analysis of 11 IVF studies found women with replete vitamin D status (>30 ng/mL) had significantly higher rates of clinical pregnancy and live birth compared to women who were deficient (<20 ng/mL), with the effect more pronounced in women undergoing fresh transfers. [6] Vitamin D receptors are expressed on ovarian granulosa cells, the endometrium, and the placenta, and adequate vitamin D appears important for follicular maturation, endometrial receptivity, and early implantation. Get a 25(OH)D blood test rather than guessing — most women trying to conceive in non-tropical latitudes need 2,000–4,000 IU/day to reach the 30–60 ng/mL range associated with the best outcomes.

See our vitamin D page for testing and dosing details.

Omega-3: The Fecundability Boost

Omega-3 fatty acids — particularly EPA and DHA from cold-water fish — are essential for cell membrane fluidity, anti-inflammatory eicosanoid production, and the corpus luteum's progesterone output after ovulation. A 2022 prospective cohort of 900 women trying to conceive found that those taking omega-3 supplements were 1.5 times more likely to conceive in any given cycle (fecundability ratio 1.51, 95% CI 1.12–2.04) compared to non-users, after adjusting for diet, BMI, and other factors. [7] Two to three grams per day of combined EPA+DHA from a quality fish oil, krill oil, or algae oil (for vegans) is the typical clinical target.

See our omega-3 page and our wild salmon page for sources.

Reducing Pesticide Exposure

A 2018 prospective cohort of 325 women undergoing IVF at Massachusetts General Hospital found that women in the highest quartile of high-pesticide-residue fruit and vegetable intake had 18% fewer pregnancies and 26% fewer live births compared to women in the lowest quartile. [3] High-pesticide-residue items include conventionally grown strawberries, spinach, kale, peaches, pears, apples, grapes, cherries, peppers, and tomatoes. Switching these to organic — or using the EWG's "Dirty Dozen" list — is one of the more cost-effective interventions in the literature, with replicated effects on actual pregnancy outcomes rather than just biomarkers.

See our organic food page, glyphosate page, and atrazine page for more on specific pesticide concerns.

Sleep, Stress, and the HPA-Ovarian Axis

Cortisol — the body's main stress hormone — communicates directly with the ovary. Chronic elevations suppress GnRH from the hypothalamus, which downregulates LH and FSH, which in turn impairs follicle recruitment, ovulation, and corpus luteum function. Women trying to conceive should treat sleep and stress as fertility variables: aim for 7–9 hours of consistent sleep, address chronic stressors where possible, and consider gentle practices like yoga, meditation, or walking rather than over-exercising. High-volume endurance training and severe caloric restriction can both suppress ovulation through low energy availability — this is one of the few areas where "more exercise" can be counterproductive.

Evidence Review

The literature on female fertility nutrition has grown substantially over the past two decades, with a few large prospective cohorts and well-conducted randomised controlled trials providing the strongest signals.

Chavarro et al. (2007) — Nurses' Health Study II. This is the cornerstone observational study. The authors followed 17,544 married women without a history of infertility from 1991 to 1999, recording 438 cases of incident infertility (3,209 from ovulatory disorder, 232 from other causes). The "fertility diet" score combined eight dietary and lifestyle factors. After adjustment for age, parity, BMI, smoking, physical activity, oral contraceptive use, and total energy intake, women in the highest fertility diet quintile had a relative risk for ovulatory infertility of 0.34 (95% CI 0.23–0.49) compared to the lowest quintile. [1] The strongest individual contributors were monounsaturated fat (replacing trans fat), vegetable rather than animal protein, low-glycaemic carbohydrate, full-fat (vs low-fat) dairy, and multivitamin use. The full-fat dairy finding was unexpected at the time but has been consistent across follow-up analyses, possibly reflecting a hormonal effect of dairy fat on ovarian steroidogenesis.

Toledo et al. (2011) — SUN Project. A nested case-control study of 485 Spanish women, 96 of whom consulted physicians for difficulty becoming pregnant. After adjustment for age, BMI, energy intake, smoking, education, and physical activity, women in the highest tertile of Mediterranean diet adherence had an odds ratio for difficulty conceiving of 0.56 (95% CI 0.30–1.06) compared to the lowest tertile. [2] Although the confidence interval crosses 1.0, the 44% point-estimate reduction is consistent with the Nurses' Health findings and reinforces the broader Mediterranean dietary pattern as the most evidence-supported eating approach for fertility.

Chiu et al. (2018) — JAMA Internal Medicine. A prospective cohort of 325 women undergoing 541 ART cycles at Massachusetts General Hospital between 2007 and 2016. Pesticide residue intake was estimated by combining self-reported fruit and vegetable consumption with USDA Pesticide Data Program residue measurements. Comparing the highest to the lowest quartile of high-pesticide-residue fruit/vegetable intake, the adjusted probabilities of clinical pregnancy were 0.43 vs 0.55 (P = 0.02 for trend) and live birth were 0.34 vs 0.46 (P = 0.02 for trend). [3] The authors estimated that replacing high-pesticide-residue produce with low-residue or organic equivalents would yield meaningful improvements in IVF success rates. Importantly, total fruit and vegetable intake was not associated with worse outcomes — only the high-pesticide-residue items were.

Unfer et al. (2017) — Myo-inositol Meta-Analysis. A meta-analysis of nine RCTs (n = 247 PCOS patients receiving myo-inositol; n = 249 controls) found that supplementation significantly improved ovulation frequency (OR 2.30, 95% CI 1.62–3.27) and reduced fasting insulin and HOMA-IR. [4] Studies that examined oocyte and embryo quality consistently reported improvements in mature oocyte yield and grade A embryo rates. The standard dose across trials was 4 g/day of myo-inositol, often combined with folic acid. Effects emerged within 8–12 weeks, consistent with the follicle maturation timeline.

Bentov et al. (2014) — CoQ10 RCT. A double-blind randomised pilot trial in 39 women aged 38–46 undergoing IVF/ICSI. Participants received 600 mg/day ubiquinone for 60 days before stimulation or placebo. The CoQ10 group had 46.5% aneuploid embryos vs 62.8% in the placebo group (P = 0.07). [5] The trial was terminated early because of slow recruitment and is therefore underpowered, but the direction of effect aligns with the strong mechanistic case (CoQ10's role in mitochondrial ATP production during meiotic spindle assembly) and with multiple animal studies showing rescue of age-related oocyte dysfunction. Larger, well-powered trials are still needed, but practitioners commonly recommend 200–600 mg/day for 90+ days for women 35+ given the favourable risk profile.

Chu et al. (2018) — Vitamin D Meta-Analysis. Pooled 11 prospective cohort studies of women undergoing ART (total n = 2,700). Women with replete vitamin D status had higher rates of positive pregnancy tests (OR 1.34, 95% CI 1.04–1.73) and live birth (OR 1.33, 95% CI 1.08–1.65) compared to women with deficient or insufficient status. [6] The effect was most pronounced when comparing fully replete (>30 ng/mL) to deficient (<20 ng/mL) categories, supporting the practice of testing 25(OH)D and supplementing to bring levels to at least 30 ng/mL before attempting conception.

Stanhiser et al. (2022) — Omega-3 and Fecundability. A prospective cohort of 900 women aged 30–44 trying to conceive without fertility treatment. The fecundability ratio (cycle-by-cycle probability of conception) for omega-3 supplement users vs non-users was 1.51 (95% CI 1.12–2.04) after adjustment for age, BMI, race, parity, and other factors. [7] The effect persisted after sensitivity analyses and was not explained by confounding by overall health-conscious behaviour.

Showell et al. (2020) — Cochrane Antioxidant Review. The most rigorous synthesis to date on antioxidant supplements for female subfertility. Pooled data from 63 RCTs (n = 7,760 women) found low-quality evidence that antioxidants may be associated with higher live birth rates compared to placebo or no treatment (OR 1.81, 95% CI 1.36–2.43). [8] However, the authors note significant heterogeneity in the supplements tested (CoQ10, melatonin, NAC, vitamin C, vitamin E, myo-inositol, l-arginine, l-carnitine, and various combinations) and risk of bias in many included studies. The take-home is that, on average, antioxidant supplementation appears beneficial for subfertility but the optimal regimen remains undefined.

Limitations and What This Doesn't Cover

This evidence base has clear limitations: most studies are observational rather than randomised, supplement trials are often underpowered, and effects vary substantially by underlying cause of infertility. Tubal factor infertility, severe endometriosis, advanced maternal age, and male-factor infertility may not respond meaningfully to dietary or supplement interventions and require targeted medical evaluation. The interventions described here are best understood as a foundation that supports — rather than replaces — appropriate medical workup for couples who do not conceive within 6–12 months of trying (or sooner if the woman is over 35).

Confidence Assessment

  • High confidence: Mediterranean/fertility dietary pattern reduces ovulatory infertility risk; vitamin D repletion (>30 ng/mL) improves IVF outcomes; reducing high-pesticide-residue produce intake improves IVF live birth rates; myo-inositol improves ovulation in PCOS.
  • Moderate confidence: CoQ10 supplementation supports oocyte quality in women 35+; omega-3 supplementation improves fecundability; antioxidant supplementation in general modestly improves live birth rates.
  • Lower confidence: Specific dose-response relationships for most supplements; benefit in tubal-factor or unexplained infertility; long-term effects of high-dose antioxidant cocktails on healthy women.

References

  1. Diet and lifestyle in the prevention of ovulatory disorder infertilityChavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Obstetrics and Gynecology, 2007. PubMed 17978119 →
  2. Dietary patterns and difficulty conceiving: a nested case-control studyToledo E, Lopez-del Burgo C, Ruiz-Zambrana A, Donazar M, Navarro-Blasco I, Martínez-González MA, de Irala J. Fertility and Sterility, 2011. PubMed 21943727 →
  3. Association Between Pesticide Residue Intake From Consumption of Fruits and Vegetables and Pregnancy Outcomes Among Women Undergoing Infertility Treatment With Assisted Reproductive TechnologyChiu YH, Williams PL, Gillman MW, Gaskins AJ, Mínguez-Alarcón L, Souter I, Toth TL, Ford JB, Hauser R, Chavarro JE. JAMA Internal Medicine, 2018. PubMed 29084303 →
  4. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trialsUnfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Endocrine Connections, 2017. PubMed 29042448 →
  5. Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatmentBentov Y, Hannam T, Jurisicova A, Esfandiari N, Casper RF. Clinical Medicine Insights: Reproductive Health, 2014. PubMed 25210483 →
  6. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysisChu J, Gallos I, Tobias A, Tan B, Eapen A, Coomarasamy A. Human Reproduction, 2018. PubMed 29149263 →
  7. Omega-3 fatty acid supplementation and fecundabilityStanhiser J, Jukic AMZ, McConnaughey DR, Steiner AZ. Human Reproduction, 2022. PubMed 35147198 →
  8. Antioxidants for female subfertilityShowell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Cochrane Database of Systematic Reviews, 2020. PubMed 32851663 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.